.jpg)
NorDiag ASA to be listed on Oslo Børs
The Board of Oslo Børs resolved to admit shares in NorDiag ASA to listing on the SMB List of Oslo Børs.
The Board stipulated that prior to the first day of listing the company must satisfy the requirement for at least 100 holders of one round lot or more of the company's shares set out in Oslo Børs Circular No. 5/2001. Is also a requirement that the company raises at least NOK 50 million of equity from its planned share issue and that it completes the planned conversion of a loan of NOK 10 million from Novel Diagnostics ASA to new equity. In addition, the company must be able to document a market value of at least NOK 8 million before it is admitted to listing.
The Board authorised the President of Oslo Børs to fix the date of the first day of listing, which is to be no later than 13 January 2006.
About NorDiag
NorDiag is a biotechnology company aiming to reduce mortality and treatment costs of common cancers through detection at the early, curable phases of cancer development. The Company’s first product, Genefec™, enables early detection of gastrointestinal cancers, including colorectal cancer. This diagnostic product has been sold and reimbursed in Norway since 2002. The company has already achieved clinical acceptance for Genefec™ in the local market with a yearly doubling of sales since market introduction. NorDiag is now making preparations for bringing the product out into international markets through the Company’s collaborative partners.
Deep Ocean ASA to be listed on Oslo Børs
The Board of Oslo Børs resolved to admit shares in Deep Ocean ASA to listing on the SMB List of Oslo Børs.
The Board agreed to exempt the company from the requirement that a listed company must have carried on the major part of its activities for at least three years, cf. Section 2-1 of the Stock Exchange Regulations. The exemption was granted because the activities have been in existence, but have been carried out by different legal entities.
Admission to listing is conditional on the company publishing, prior to the first day of listing, a prospectus approved by Oslo Børs in accordance with Chapters 15 and 16 of the Stock Exchange Regulations, as well as a statement of the company's adherence to the Norwegian Code of Practice for Corporate Governance in accordance with Oslo Børs Circular No. 4/2005.
The Board authorised the President of Oslo Børs to fix the date of the first day of listing, which is to be no later than 13 January 2006.
FIRM ASA to be listed on Oslo Børs
The Board of Oslo Børs resolved to admit shares in Future Information Research Management ASA (FIRM) to listing on Oslo Børs.
The Board agreed to exempt the company from the requirement that a listed company must have carried on the major part of its activities for at least three years, cf. Section 2-1 of the Stock Exchange Regulations. The exemption was granted because the activities have been in existence, but have been carried out by different legal entities.
The Board stipulated that prior to the first day of listing the company must satisfy the requirement for the minimum number of holders of one round lot or more of the company's shares set out in Oslo Børs Circular No. 5/2001.
The Board authorised the President of Oslo Børs to decide whether the company should be listed on the SMB List or the Main List and to fix the date of the first day of listing, which is to be no later than 13 January 2006.
About FIRM
Future Information Research Management (FIRM) is a leading provider of survey & reporting software for Market Research (MR) and Enterprise Insight Management (EIM). The company`s state of the art web-based platform, Confirmit, is used for customer satisfaction surveys and employee satisfaction surveys as well as market research surveys. Confirmit is used by some of the largest market research agencies in the world, in addition to Global 1000 companies. Customers include Accenture, AC Nielsen, Crown Castle, Dow Jones, Egg, Wanadoo, Greenfield Online, Hewlett-Packard, Microsoft, Mori, The NPD Group, Progressive Insurance and Symantec.FIRM is headquartered in Oslo and has offices in London, New York and San Francisco. In addition, Confirmit is distributed through partner resellers in Stockholm, Amsterdam, Sydney and Tokyo.
Funcom N.V. to be listed on Oslo Børs
The Board of Oslo Børs resolved to admit shares in Funcom N.V. to listing on the SMB List of Oslo Børs.
The Board stipulated that prior to the first day of listing the company must satisfy the requirement for at least 100 holders of one round lot or more of the company's shares set out in Oslo Børs Circular No. 5/2001, and at least 25% of the shares to be listed must be held by the general public.
Admission to listing is also conditional on the company publishing a prospectus approved by Oslo Børs in accordance with Chapter 16 of the Stock Exchange Regulations, and the company must raise at least NOK 100 million of equity from its planned share issue in order to satisfy the requirement for satisfactory liquidity. The company must also ensure that the composition of its Board of Directors is in accordance with the Norwegian Code of Practice for Corporate Governance.
The Board authorised the President of Oslo Børs to fix the date of the first day of listing, which is to be no later than 13 January 2006.
About Funcom
Funcom is a developer and publisher of massive multiplayer online (“MMO”) games and services. Through several years of game development on multiple platforms, Funcom has built one experienced teams within the MMO genre and established the technical platforms and competencies required to launch its next generation MMO. Today, the Funcom Group has 149 employees located at its offices in Küsnacht (Switzerland) (corporate headquarters), Oslo (Norway), Durham (North Carolina, USA), and Beijing (China). Of these, approximately 110 are employed within game development.
Violation charge for Deutsche Bank AG London
The Board of Oslo Børs resolved to impose a violation charge of NOK 500,000 on Deutsche Bank AG London for a breach of the reporting rules in connection with manual trades. The violation charge is imposed in accordance with Section 25-8 of the Stock Exchange Regulations and Clause 4.11.9 of the Norex Member Rules Version 1.4 September 2004 in respect of a breach of Section 12-5 of the Stock Exchange Regulations and of Clause 5.6.1 (cf. Clause 5.6.13) of the Norex Member Rules Version 1.4 September 2004.
The matter in question relates to breaches of the reporting rules in connection with a number of trades carried out in spring 2005. The trades were on a significant scale, and therefore represented important information for the market. Pursuant to Section 2 of the Freedom of Information Act, minutes with details of this matter will be published on www.oslobors.no/ob/vedtak in the near future.
This decision can be appealed to the Stock Exchange Appeals Committee in accordance with the provisions of Chapter 26 of the Stock Exchange Regulations. Any appeal must be submitted within two weeks.
